- Fan uncovers ‘Westworld’ trailers hidden on fictional company’s website Sunday 8:18 PM
- This trending Twitter hashtag is a lot less sexy than you think Sunday 7:23 PM
- TikTok users share life-changing realizations they’ve had while in the shower Sunday 7:04 PM
- People are torn over viral TikTok of girl cleaning friend’s room Sunday 4:01 PM
- Did Pete Buttigieg seriously just rip-off a famous Obama speech? Sunday 2:50 PM
- The most dangerous TikTok challenges we’ve seen—so far Sunday 2:22 PM
- PewDiePie wants Bernie Sanders to host meme review Sunday 1:44 PM
- Hilary Duff records confrontation with ‘creep’ taking photos of kids Sunday 1:08 PM
- BTS may have used Twitch streamer’s voice in song without permission Sunday 12:15 PM
- Gigi Hadid absolutely obliterates Jake Paul over Zayn Malik diss Sunday 10:26 AM
- People really want Chris Matthews fired after he compared Sanders’ Nevada win to Nazi invasion of France Sunday 9:35 AM
- Bernie Sanders wins Nevada Caucuses Saturday 6:54 PM
- MSNBC is out of its mind over Sanders leading Nevada Saturday 5:20 PM
- Kim Kardashian dragged for using makeup to darken her hands Saturday 4:13 PM
- TikTok users show how they turned their vehicles into incredible tiny homes Saturday 3:44 PM
You didn’t swallow your sensor today, did you? That’s how a conversation with your angry doctor could start in the near future.
The Food and Drug Administration on Monday approved the first “digital pill” in the U.S. that uses sand-grain-sized embedded sensors to track when a patient takes their medication. The pill, called Abilify MyCite, sends information to a patch patients wear on the left side of their rib cage, which then transmits data to a smartphone app.
The sensor, made of copper, magnesium, and silicon—safe ingredients found in foods—triggers an electrical signal when touched by acid. A few minutes after ingestion, the pill contacts stomach acid and sends a signal to the Band-Aid-like patch. The patch then transmits time and dosage information to a smartphone app using standard Bluetooth protocol.
Privacy groups are concerned the pills will be used to punish patients who don’t take them, while others question why the first approved pill is used to treat patients with schizophrenia who can become paranoid about doctors.
“You would think that, whether in psychiatry or general medicine, drugs for almost any other condition would be a better place to start than a drug for schizophrenia,” Dr. Paul Appelbaum, director of law, ethics, and psychiatry at Columbia University, told the New York Times.
Patients can sign consent forms to allow doctors and four other people, like caretakers or family members, to receive a time log of when they take their medication. The hope is that the pill will solve problems with patients not taking their medications, which the IMS Institute estimates costs the industry more than $200 million each year.
Abilify MyCite is a collaboration between the company that makes the medicine, Otsuka, and the sensor creator Proteus Digital Health. Abilify is used to treat schizophrenia, bipolar disorder, and severe depression.
H/T the Verge
Phillip Tracy is a former technology staff writer at the Daily Dot. He's an expert on smartphones, social media trends, and gadgets. He previously reported on IoT and telecom for RCR Wireless News and contributed to NewBay Media magazine. He now writes for Laptop magazine.